Data Checks Before Registering Study Protocols for Health Care Database Analyses.
Wang SV, Schneeweiss S.
JAMA. 2024 Apr 08. PMID: 38587830
Sebastian Schneeweiss is Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine, Brigham and Women’s Hospital, a world-leading research and training center.
His research is funded by multiple NIH, PCORI, BWF, and FDA grants and focuses on the comparative effectiveness and safety of biopharmaceuticals. He has developed analytic methods to improve the scientific validity of epidemiologic analyses using complex longitudinal healthcare databases particularly for newly marketed medical products. Applying such methods in rapid analysis cycles for sequential medication effectiveness monitoring and rapid response analyses is the overarching theme of his research. He is Aetion Inc.’s co-founder and Science Advisor were he develops a range of rapid-cycle analytics platforms for healthcare database networks around the world.
Dr. Schneeweiss is PI of the Sentinel Innovation Center funded by FDA/CDER were he is a voting consultant to the FDA Drug Safety and Risk Management Advisory Committee. He was an inaugural member of the Methods Committee of the Patient-Centered Outcomes Research Institute. He is Past President of the International Society for Pharmacoepidemiology and is Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology.
At Harvard he teaches courses on Database Analytics for Pharmacoepidemiology (EPI286) and on Effectiveness Research in Longitudinal Healthcare Databases (EPI253), Medications and Evidence (AISC604) among others.
He received his medical training at the University of Munich Medical School and his doctoral degree from Harvard.
Wang SV, Schneeweiss S.
JAMA. 2024 Apr 08. PMID: 38587830
Schneeweiss S, Wang SV.
JAMA Intern Med. 2024 Apr 01. 184(4):446. PMID: 38345785
Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, Oduol T, Huisingh C, Lin KJ.
Pharmacoepidemiol Drug Saf. 2024 Apr. 33(4):e5782. PMID: 38566351
Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E.
Diabetologia. 2024 Mar 21. PMID: 38509341
Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E.
Cardiovasc Diabetol. 2024 Mar 18. 23(1):103. PMID: 38500096
Lin KJ, Singer DE, Avorn J, Heist EK, Sreedhara SK, Anand P, Zhang Y, Tsacogianis TN, Schneeweiss S.
Circ Cardiovasc Qual Outcomes. 2024 03. 17(3):e010279. PMID: 38440888
Schneeweiss MC, Shay D, Ly S, Wyss R, Schneeweiss S, Glynn RJ, Mostaghimi A.
JAMA Dermatol. 2024 Mar 01. 160(3):334-340. PMID: 38294794
Desai RJ, Wang SV, Sreedhara SK, Zabotka L, Khosrow-Khavar F, Nelson JC, Shi X, Toh S, Wyss R, Patorno E, Dutcher S, Li J, Lee H, Ball R, Dal Pan G, Segal JB, Suissa S, Rothman KJ, Greenland S, Hernán MA, Heagerty PJ, Schneeweiss S.
BMJ. 2024 02 12. 384:e076460. PMID: 38346815
Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E.
Cardiovasc Diabetol. 2024 02 08. 23(1):57. PMID: 38331813
Heyard R, Held L, Schneeweiss S, Wang SV.
BMJ Med. 2024. 3(1):e000709. PMID: 38348308